טוען...
PF-04494700, an Oral Inhibitor of Receptor For Advanced Glycation End Products (RAGE), in Alzheimer’s disease
OBJECTIVE: To evaluate the safety and tolerability of PF-04494700, an oral Inhibitor of receptor for advanced glycation end products (RAGE), in subjects with mild-to-moderate dementia of the Alzheimer’s type. METHODS: Subjects 50 years and older who met NINCDS-ADRDA criteria for AD with an MMSE scor...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3346183/ https://ncbi.nlm.nih.gov/pubmed/21192237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0b013e318204b550 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|